针对大麻类证券的清算所限制

斯图加特交易所(Boerse Stuttgart)和明讯银行(Clearstream Banking)宣布其将不再对主营业务与大麻及其它毒品直接或间接相关的证券提供服务。因此,该等证券将不会再于斯图加特(SWB)或法兰克福(FWB)证券交易所交易。自2018年9月19日收盘开始,IBKR将采取以下行动:

  1. 对于客户未采取行动平仓,但也不能转至美国挂牌市场的受影响头寸,进行强制平仓;
  2. 对于客户未采取行动平仓,但能够转至美国挂牌市场的受影响头寸,将股票转至其美国挂牌市场。

下方表格列出了斯图加特交易所和明讯银行截至2018年8月7日公布的受影响证券。该表格还标记了受影响证券是否能够转至美国挂牌市场。注意,清算所已声明该列表可能尚不完整,建议客户检查其各自网站了解最新信息。

ISIN 名称 交易所 是否可转至美国? 美国代码
CA00258G1037

ABATTIS BIOCEUTICALS CORP

FWB2

ATTBF

CA05156X1087

AURORA CANNABIS INC

FWB2, SWB2

ACBFF

CA37956B1013

GLOBAL CANNABIS APPLICATIONS

FWB2

FUAPF

US3988451072

GROOVE BOTANICALS INC

FWB

GRVE

US45408X3089

INDIA GLOBALIZATION CAPITAL

FWB2, SWB2

ICG

CA4576371062

INMED PHARMACEUTICALS INC

FWB2

IMLFF

CA53224Y1043

LIFESTYLE DELIVERY SYSTEMS I

FWB2, SWB2

LDSYF

CA56575M1086

MARAPHARM VENTURES INC

FWB2, SWB2

MRPHF

CA5768081096

MATICA ENTERPRISES INC

FWB2, SWB2

MQPXF

CA62987D1087

NAMASTE TECHNOLOGIES INC

FWB2, SWB2

NXTTF

CA63902L1004

NATURALLY SPLENDID ENT LTD

FWB2, SWB2

NSPDF

CA88166Y1007

TETRA BIO-PHARMA INC

FWB2

TBPMF

CA92347A1066

VERITAS PHARMA INC

FWB2

VRTHF

CA1377991023

CANNTAB THERAPEUTICS LTD

FWB2  
CA74737N1042

QUADRON CANNATECH CORP

FWB2  
CA84730M1023

SPEAKEASY CANNABIS CLUB LTD

FWB2, SWB2  
CA86860J1066

SUPREME CANNABIS CO INC/THE

FWB2  
CA92858L2021

VODIS PHARMACEUTICALS INC

FWB2  

 重要注意事项:

  • 请注意,美国挂牌证券通常为场外交易(PINK),且以美元(而非欧元)计价,因此,除市场风险外,您还将面对汇率风险。
  • 持有粉单(PINK Sheet)证券的账户持有人需要有美国(仙股)交易许可才能下达开仓定单。
  • 拥有美国(仙股)交易许可之账户的所有使用者均须使用双因素验证登录账户。

Clearinghouse Restrictions on Cannabis Securities

Boerse Stuttgart and Clearstream Banking have announced that they will no longer provide services for issues whose main business is connected directly or indirectly to cannabis and other narcotics products.  Consequently, those securities will no longer trade on the Stuttgart (SWB) or Frankfurt (FWB) stock exchanges. Effective as of the 19 September 2018 close, IBKR will take the following actions:

  1. Force close any impacted positions which clients have not acted to close and that are not eligible for transfer to a U.S. listing; and
  2. Force transfer to a U.S. listing any impacted positions which clients have not acted to close and that are eligible for such transfer.

Outlined in the table below are impacted issues as announced by the Boerse Stuttgart and Clearstream Banking  as of 7 August 2018. This table includes a notation as to whether the impacted issue is eligible for transfer to a U.S. listing. Note that the clearinghouses have indicated that this list may not yet be complete and clients are advised to review their respective websites for the most current information.

ISIN NAME EXCHANGE U.S. TRANSFER ELIGIBLE? U.S. SYMBOL
CA00258G1037

ABATTIS BIOCEUTICALS CORP

FWB2 YES

ATTBF

CA05156X1087

AURORA CANNABIS INC

FWB2, SWB2 YES

ACBFF

CA37956B1013

GLOBAL CANNABIS APPLICATIONS

FWB2 YES

FUAPF

US3988451072

GROOVE BOTANICALS INC

FWB YES

GRVE

US45408X3089

INDIA GLOBALIZATION CAPITAL

FWB2, SWB2 YES

ICG

CA4576371062

INMED PHARMACEUTICALS INC

FWB2 YES

IMLFF

CA53224Y1043

LIFESTYLE DELIVERY SYSTEMS I

FWB2, SWB2 YES

LDSYF

CA56575M1086

MARAPHARM VENTURES INC

FWB2, SWB2 YES

MRPHF

CA5768081096

MATICA ENTERPRISES INC

FWB2, SWB2 YES

MQPXF

CA62987D1087

NAMASTE TECHNOLOGIES INC

FWB2, SWB2 YES

NXTTF

CA63902L1004

NATURALLY SPLENDID ENT LTD

FWB2, SWB2 YES

NSPDF

CA88166Y1007

TETRA BIO-PHARMA INC

FWB2 YES

TBPMF

CA92347A1066

VERITAS PHARMA INC

FWB2 YES

VRTHF

CA1377991023

CANNTAB THERAPEUTICS LTD

FWB2 NO  
CA74737N1042

QUADRON CANNATECH CORP

FWB2 NO  
CA84730M1023

SPEAKEASY CANNABIS CLUB LTD

FWB2, SWB2 NO  
CA86860J1066

SUPREME CANNABIS CO INC/THE

FWB2 NO  
CA92858L2021

VODIS PHARMACEUTICALS INC

FWB2 NO  

 IMPORTANT NOTES:

  • Note that the U.S. listings generally trade over-the-counter (PINK) and are denominated in USD not EUR thereby exposing you to exchange rate risk in addition to market risk.
  • Account holders maintaining PINK Sheet securities require United States (Penny Stocks) trading permissions in order to enter opening orders.
  • All users on accounts maintaining United States (Penny Stocks) trading permissions are required use 2 Factor login protection when logging into the account.

中国股票交易“北向通”投资者ID模型

背景
2017年11月,香港证监会(SFC)和中国证监会(CSRC)宣布就大陆-香港股票互联互通机制下的“北向通”交易推出投资者识别体系。该体系旨在增强对香港投资者交易大陆股票的合规监管,要求经纪商向上海证交所或深圳交易所报告客户的身份。 该法规自2018年9月26日起生效。 更多信息请见以下常见问题。
 
什么是股票互联互通?
股票互联互通机制是香港、上海和深圳证券交易所间的合作项目,该机制使国际投资者和中国大陆投资者得以通过其所属交易所的交易和清算设施交易其它证券交易所的证券。
 
什么是“北向通”交易?
“北向通”交易是指通过香港证券交易所交易在中国大陆上市的股票(即在上交所或深交所上市的股票)。
 
要收集和报告的是什么信息?
要收集和报告的信息取决于客户分类。对于个人,要收集和报告的信息如下:
  • 中英文姓名
  • 身份证件的签发国家/司法辖域
  • 身份证件类型(香港身份证、相关国家/地区政府机关签发的身份证、护照、或其它任意官方的身份证明文件,如驾照)
  • 身份证号码(身份证明文件号码)
对于机构投资者,要收集和报告的信息如下:
  • 实体名称
  • 其它正式的成立文件(IBKR会尽可能使用客户开户时提供的文件)。
  • 法律实体识别号码(如您没有LEI,您可在请求“互联互通”交易许可时通过IBKR申请一个。请注意,申请LEI最长可能需要三天,需向LEI签发机构缴纳申请费,之后每年还需续费)
每位“北向通”交易客户都会被分配一个“经纪商至客户分配号码(BCAN)”,该号码将与收集来的识别信息挂钩,并用于实时标注每一笔“北向通”定单。
 
IBKR被授权向谁分享此类信息?
想通过股票互联互通机制交易的客户必须同意IBKR向香港交易及结算所有限公司和中国的监管机构提供其信息,其中中国的监管机构包括:
  • 上海和深圳证券交易所
  • 中国证券登记结算(香港)有限公司
  • 中国大陆的监管机构和执法机关
 
IBKR如何收集此类信息?
已有“北向通”交易许可的客户在登录账户管理时即会看到一份在线表格。该表格将授权IBKR收集必要的信息并就提交定单时分享该信息征求客户同意。
 
客户识别将于何时实施?
“北向通”投资者ID模型将于2018年10月22日实施。 
 
是否会有“南向通”投资者ID模型?
SFC和CSRC也同意在“北向通”投资者ID模型成功实施后尽快为“南向通”建立类似的投资者识别体系。
 
如果我不提供必要的信息会怎么样?
“北向通”投资者ID模型实施后,客户若不提供必要的信息或不同意我们报告必要的信息,则其将无法提交“北向通”开仓定单,但可平仓已有头寸。
 
怎样才能交易中国股票互联互通机制下的股票?
要交易中国股票互联互通机制下的股票,客户需登录账户管理请求相应的交易许可:设置 -> 账户设置 -> 交易许可 -> 香港/中国股票互联互通。
 
请求了相应的交易许可后,系统会弹出“北向通”交易者披露。客户给予同意后,IBKR会分配一个BCAN并在香港时间下午2:45之前将客户文件发送给香港交易及结算所有限公司。如果请求获批,客户在第二天便可开始交易。

China Connect Northbound Investor ID Model

Background
In November 2017, the Securities and Futures Commission (SFC) and China Securities Regulatory Commission (CSRC) announced an agreement to introduce an investor identification regime for Northbound trading under Mainland-Hong Kong Stock Connect. This regime is intended to enhance regulatory surveillance of mainland-listed stock trading from Hong Kong and requires brokers to report the identity of clients submitting orders to either the Shanghai or Shenzhen Stock Exchange.  This regulation will be effective as of September 26, 2018.  Additional information is provided in the series of FAQs below.
 
What is the Stock Connect?
The Stock Connect is a collaboration between the Hong Kong, Shanghai and Shenzhen Stock Exchanges which allows international and Mainland Chinese investors to trade securities in each other's markets through the trading and clearing facilities of their home exchange.
 
What is Northbound trading?
Northbound trading refers to the trading of mainland-listed stocks (e.g., Shanghai and Shenzhen Stock Exchanges) from the Hong Kong Stock Exchange.
 
What information is being collected and reported?
The information collected and reported depends upon the client classification. In the case of individuals, the information is as follows:
  • Name in English and Chinese
  • ID issuing country/jurisdiction
  • ID type (Hong Kong ID card, ID card issued by the government authority of relevant country/region, passport, or any other official identity document e.g. driver's license)
  • ID number (number of ID document)
For Institutional investors, the information is as follows:
  • Entity name
  • Other official incorporation documents (IBKR will attempt to us the documents clients provided at the point of account opening, whenever possible).
  • Legal Entity Identifier (if you do not already have an LEI, you can order one through IBKR when requesting trading permissions for China Connect. Note that obtaining a LEI can take up to three days, is associated with an application fee imposed by the LEI issuing organization, and an annual renewal fee thereafter).
Each Northbound trading client will be assigned a Broker-to-Client Assigned Number (BCAN) which will be associated with the identification information collected and will be tagged to every Northbound order on a real-time basis.
 
Who is IBKR authorized to share this information with?
Clients who wish to access the Stock Connect must provide IBKR with consent to provide their information to the Hong Kong Exchanges and Clearing Ltd and the Chinese regulatory bodies such as:
  • Shanghai and Shenzhen Stock Exchanges
  • China Securities Depository and Clearing (Hong Kong) Company Limited
  • Mainland regulatory authorities and law enforcement agencies
 
How will IBKR collect this information?
Clients with existing Northbound trading permissions will be presented with the online form upon log in to Account Management. This form will allow IBKR to collect the required information and consent to submit this information upon order submission.
 
When will the identification take place?
The Northbound Investor ID model will be effective as of October 22, 2018. 
 
Will there be a Southbound Investor ID model?
The SFC and the CSRC also agreed to introduce a similar investor identification regime for Southbound trading as soon as possible after the regime for Northbound trading is implemented.
 
What happens if I do not provide the required information?
Once the Northbound Investor ID model is in effect, clients who either fail to provide the required information or elect not to provide consent to report the required information will not be allowed to submit opening Northbound orders but will be allowed to close existing positions.
 
How can I trade China Connect Stocks?
In order to trade China Connect stocks clients are required to login to Account Management and request the necessary trading permissions in Settings -> Account Settings -> Trading Permissions -> Hong Kong/China Stock Connect.
 
After the trading permission has been requested clients will be prompted with the Northbound Trader Disclosure. Once consent has been given, IBKR will assign a BCAN and send the client file to the HKEX before the deadline at 2:45pm HKT. If the request has been approved, clients will be able to trade on the next day.

Utilization in the Securities Lending Market

Utilization Metrics

Utilization is defined as loaned shares divided by available shares in the securities lending market, expressed as a percentage. The Utilization metric on TWS is not specific to IB. It is based on industrywide data provided by a securities finance data vendor. The metric is not conclusive however, as not every lender reports their Utilization to the vendor. In addition, although the source is believed to be reliable, IBKR does not warrant its accuracy.

Generally, Utilization is the ratio of demand to supply. For example, Apple Inc. (AAPL) may have utilization of less than 1% because the stock has vast availability relative to the demand to borrow shares for shorting. Roku Inc. (ROKU) may have utilization above 90% because of higher demand to short shares as compared to the number of available shares.

For accounts enrolled in the Stock Yield Enhancement Program, a high stock-specific Utilization percentage may increase the likelihood that IB may be able to lend your shares. Conversely, stocks with a low Utilization percentage are generally in lesser demand in the securities finance market, generally reducing IB’s ability to lend your shares.

Utilization can be added as a column in TWS.

Using Mosaic Market Scanner to Determine an Indication of Stock Utilization

TWS users can find stock utilization indications by using Mosaic Market Scanner filters. After opening the scanner, Select Custom Scanner and input parameters. Some useful filters include Price, Market Cap, Fee Rate and Utilization.

Please also see Important Considerations and Risks of Participating in Interactive Brokers Fully-Paid Securities Lending Programs here

 

添加/消耗流动性

Overview: 

本文旨在对交易所费用、添加/消耗流动性费用以及非组合佣金提供正确的理解。

 

添加或消耗流动性的概念既适用于股票,也适用于股票/指数期权。一个定单是消耗流动性还是添加流动性,取决于定单是适销还是非适销。

适销定单会消耗流动性。
适销定单要么是市价定单,要么是限价等于或高于/低于当前市价的买入/卖出限价定单。

1. 对于适销的买入限价定单,限价等于或高于卖价。

2. 对于适销的卖出限价定单,限价等于或低于买价。

举例:
XYZ股票当前卖价尺寸/价格为400股/46.00。您输入一个买入限价定单,即以46.01的价格买入100股XYZ股票。由于定单马上就能执行,其将被视为适销定单。如果交易所会对消耗流动性收费,则客户将需缴纳该费用。


 

非适销定单会添加流动性。
非适销定单是限价低于/高于当前市价的买入/卖出限价定单。

1. 对于非适销的买入限价定单,限价低于卖价。

2. 对于非适销的卖出限价定单,限价高于买价。

举例:
XYZ股票当前卖价尺寸/价格为400股/46.00。您输入一个买入限价定单,即以45.99的价格买入100股XYZ股票。由于定单将被作为最佳买价发布至市场,而不会立即执行,其将被视为非适销定单。
若有人发送了一个适销的卖出定单,从而使您的买入限价定单得以执行,则如果有添加流动性返点,您会收到一定折扣(返点)。

请注意:
1. 所有交易期权的账户均需就消耗/添加流动性缴纳/享受期权交易所费用或返点。
2. 根据IB网站,消耗/添加流动性费用表下只有负数才是折扣(返点)。

https://www.ibkr.com.cn/cn/index.php?f=2356
股票与期权佣金/费用请参见上方链接。

T+2结算概述

简介

从2017年9月5日起,在美国和加拿大交易所交易的证券的标准结算时间将从3个工作日(T+3)缩短至2个工作日(T+2)。下文介绍了有关本变化、其预期影响及常见问题的背景信息。
 
背景
结算是一种交易后流程,即,使证券的所有权从卖方转移至买方,同时由买方支付对价的过程。中央托管人和清算所会促进该过程完成——中央托管人会维护证券所有权的记录,清算所则处理资金往来,并向托管人发出指令,要求其转移证券所有权。对于美国证券,主要托管人是存款信托公司(DTC),清算所则是全国证券清算公司(NSCC)。加拿大证券存管处(CDS)为加拿大证券发挥此类功能。 目前美国和加拿大证券的结算周期都是交易日之后的3个工作日。
 
结算周期为何变化?
鉴于现在托管人能够以电子形式登记证券的所有权,客户能够通过电子化的形式以低成本方便地转移资金,运营效率得到了提升,这是促进结算周期缩短的关键因素。结算周期上一次缩短发生在1995年,当时周期从5个工作日缩短至了3个工作日,而涉及交付实体单证及通过支票付款的交易不断减少。
 
缩短结算周期将给行业和市场参与者带来以下好处:
 
  • 降低金融系统的风险 – 由于证券价格变动的可能性会随时间上升,缩短结算周期能降低由于未付款或未交付证券导致的信用风险敞口。 通过降低待结算义务的名义价值,能够提高金融系统抵御严重市场冲击带来的潜在系统性后果。 
  • 提高现金调用效率 – 对于持“现金”账户的客户,若资金结算未完成,则无法交易(即不得空买空卖——在不支付的情况下买卖证券)。 实施T+2制度后,销售证券所得的资金将比之前早一个工作日到账,因此客户将能更快地将资金用于后续交易。 
  • 提高全球结算一致性 - 当前欧洲和亚洲等市场实行T+2制度,向T+2结算周期的转变将使美国和加拿大市场更好地与其它主要国际市场接轨。
 
哪些产品将受此改变影响?
美国和加拿大股票、ETF、ADR、公司债券、市政债券、差价合约以及单位投资信托(UITs)
 
此次变化会如何影响我的账户?
股息和公司行动 – 证券必须在除息日之前买入方可享受股息或其它和证券相关的权利。   在当前T+3的结算周期下,除息日通常比登记日早2个工作日,在T+2制度下,除息日领先登记日的时间将缩短至1个工作日。
 
卖空交易 – 美国证监会(SEC)的204号法规要求经纪商在结算日无法借到股票进行交付的情况下平仓卖空单。目前,平仓必须在T+4个交易日常规交易时间开市前完成。结算周期缩短至T+2后,平仓也将提早一个工作日至T+3。
 
T+2定单目的地 – IB目前提供定单目的地(TPLUS2),允许持保看涨期权的卖方在期权被行权时买入并交付成本基础较有利的股票。该T+2定单能降低潜在的资本利得税,且将被改至T+1交付,以便提供相同的好处。 请知悉,该T+2定单目的地在2017年9月5日之前将被禁用,而T+1定单目的地在该日期后不久将被启用(即,有一个过渡期,期间新的结算定单目的地不会被提供)。
 
期权行权 – 股票交付周期及股票期权行权导致的现金支付周期将从3个工作日缩短至2个工作日。
 
向贷记余额支付的利息 – 利息计算基于已结算的现金余额。如您在购买股票时有足够的现金全额支付(即不动用保证金借贷),那么买入该股票所需的资金目前可获得直至T+3日被支付给清算所前的利息。 在T+2制度下计息时间将缩短1个工作日。然而,当证券被卖出时,T+2制度下资金将提早1个工作日被记入您的账户并获得利息。 
 
向借记余额收取的利息 – 利息计算基于已结算的现金余额。如您借入资金以购买股票(即动用保证金借贷),那么在资金于T+3日被交付给清算所之前您无需对该借款支付利息。 在T+2制度下贷款起始日期将提早1个工作日。然而,当证券被卖出时,T+2制度下资金也将提早1个工作日被记入您的账户,用于部分或全额支付贷款。   
 
常见问题解答

买卖期权、期货或期货期权合约的结算规则是否会变化?

不要。此类产品当前在T+1日结算,结算周期不变。

 
买卖共同基金的结算规则是否会变化?
不要。IB当前提供的所有共同基金都在T+1日结算, 结算周期不变。
 
本次改变对发起定单所需的现金或资产是否会有影响?
不要。当前在所有定单提交前系统都会事先检查,以确保定单执行后账户的合规性。对于现金账户中的现金而言,这意味着不论是T+3还是T+2结算制度,账户都必须有足够的现金以满足结算需求。同样地,对于保证金账户,账户必须有足够的超额净资产以满足保证金要求。该保护机制在T+2制度下不会变化。
 
本次变化对通过ACATS或ATON转移证券的时间周期有无影响?
不要。T+3至T+2的变化对转账流程没有影响。

Overview of T+2 Settlement

Introduction

Effective September 5, 2017, the standard settlement period for securities traded on U.S. and Canadian exchanges will be reduced from 3 business days (T+3) to 2 business days (T+2). Background information regarding this change, its projected impact and a list of FAQs are outlined below.
 
Background
Settlement is a post-trade process whereby legal ownership of securities is transferred from the seller to the purchaser in exchange for payment.  This process is facilitated via a central depository which maintains security ownership records and a clearinghouse which processes the exchange of funds and instructs the depository to transfer ownership of the securities. For U.S. securities, the Depository Trust Company (DTC) operates as the primary depository and the National Securities Clearing Corporation (NSCC), the clearinghouse. The Canadian Depository for Securities (CDS) performs these functions for Canadian securities. The current settlement cycle for both U.S. and Canadian securities is 3 business days following the trade date.
 
Why is the settlement period changing?
Operational efficiencies afforded by registering securities ownership in an electronic form and the ease and low cost by which clients may transfer funds electronically are critical factors enabling the shortening of the settlement cycle. The settlement cycle was last reduced from 5 business days to 3 in 1995 and transactions involving the delivery of physical certificates or payment via check continue to decline.
 
Shortening the settlement cycle is expected to yield the following benefits for the industry and its participants:
 
  • Lessens risk to the financial system – the likelihood that the price of a given security will change increases over time and reducing the settlement day lessens exposure to credit risk due to non-payment or non-delivery of that security. By reducing the notional value of outstanding obligations in the settlement pipeline, the financial sector is better protected from the potential systemic consequences of serious market disruptions. 
  • Cash deployment efficiencies – clients who maintain “Cash” type accounts are subject to restrictions which may preclude them from trading with unsettled funds (i.e., “Free-Riding” or buying and selling a security without paying for it). With T+2, funds from the sale of a security will now be available 1 business day earlier, thereby providing quicker access to funds and the ability to redeploy them sooner for subsequent purchases. 
  • Enhanced global settlement harmonization - the transition to a T+2 settlement cycle will align the U.S. and Canadian markets with other major international markets in Europe and Asia that currently operate in a T+2 environment.
 
What products are impacted by this change?
U.S. and Canadian stocks, ETFs, ADRs, corporate bonds, municipal bonds, CFDs, and unit investment trusts (UITs)
 
How will this change impact my account?
Dividends & corporate actions – securities must be purchased prior to the Ex-Date for entitlement to dividends or other rights associated with the security.    Under the current T+3 settlement cycle, the Ex-Date is typically 2 business days prior to the Record Date and this relationship will be reduced to 1 business day under T+2.
 
Short sale transactions – brokers are required under SEC Rule 204 to close out short sales if unable to borrow securities and make delivery at settlement. Currently, close out must take place by no later than the beginning of regular trading hours on T+4.  With the shortening of the settlement cycle to T+2, close out will be moved up 1 business day to T+3.
 
T+2 Order Destination – IB currently offers an order destination (TPLUS2) which allows covered call writers to purchase and deliver, upon assignment, shares having a more favorable cost basis. This T+2 order, which reduces the possibility of triggering an unwanted capital gains tax, will be amended to T+1 delivery in order to provide the same benefits.  Note that this T+2 order destination will be disabled prior to September 5, 2017 and the T+1 order destination enabled shortly after that date (i.e., there will be a transition period during which this accelerated settlement order destination will not be offered).
 
Option Exercise – The delivery period for stock and payment of cash resulting from the exercise of stock options will be reduced from 3 business days to 2.
 
Interest paid on credit balances – interest computations are based upon settled cash balances. If you purchase stock and have sufficient cash to pay for the purchase in full (i.e., no margin loan), the proceeds necessary to pay for that stock are currently eligible to earn interest up until T+3 at which point they are remitted to the clearinghouse. That interest earning period will be reduced by 1 business day under T+2. Note, however, that when that security is sold the funds settle to your account 1 business day earlier under T+2 and are then eligible to earn interest. 
 
Interest charged on debit balances – interest computations are based upon settled cash balances. If you purchase stock and borrow funds to pay for the purchase (i.e., a margin loan), interest is not charged on the loan until payment is remitted to the clearinghouse on T+3. That loan date will start 1 business day earlier under T+2. Note, however, that when that security is sold, the proceeds are credited to your account and will partially or fully pay of the loan 1 business day earlier under T+2.   
 
FAQs

Will the settlement for purchases and sales of options, futures or futures options contracts change?

No. These products currently settle on T+1 and that settlement cycle will not change.

 
Will the settlement for purchases and sales of mutual funds change?
No. All mutual funds offered by IB currently settle on T+1 and that settlement cycle will not change.
 
Will this change have any impact upon the cash or assets required to initiate an order?
No. All orders are currently pre-checked prior to submission to ensure that the account will be compliant were the order to execute. In the cash of cash accounts, that means that the account must have the necessary settled cash on hand to meet the settlement regardless of T+3 or T+2.  Similarly, in the case of margin accounts, the account must have the necessary Excess Equity to remain margin compliant. This safeguard will not change under T+2.
 
Will this change have any impact upon the timeframe by which securities are transferred via ACATS or ATON?
No. Transfer processes will not be impacted by the move from T+3 to T+2.

U.S. Microcap Stock Restrictions

Introduction
To comply with regulations regarding the sale of unregistered securities and to minimize the manual processing associated with trading shares that are not publicly quoted, IBKR imposes certain restrictions on U.S. Microcap Stocks. A list of those restrictions, along with other FAQs relating to this topic are provided below. 

Microcap Restrictions

  • IBKR will only accept transfers of U.S. Microcap stocks from Eligible Clients. Eligible Clients include accounts that: (1) maintain equity (pre or post-transfer) of at least $5 million or, clients of financial advisors with aggregate assets under management of at least $20 million; and (2) have less than half of their equity in U.S. Microcap stocks.
  • IBKR will only accept transfers1 of blocks of U.S. Microcap stocks where the Eligible Client can confirm the shares were purchased on the open market or registered with the SEC;
  • IBKR will not accept transfers1 of or opening orders for U.S. Microcap Stocks designated by OTC as Caveat Emptor or Grey Market from any client. Clients with existing positions in these stocks may close the positions;
  • Execution-only clients (i.e., execute trades through IBKR, but clear those trades elsewhere) may not trade U.S. Microcap Stocks within their IBKR account. (IBKR may make exceptions for U.S.-registered brokers);


Microcap FAQs

What is a U.S. Microcap Stock?
The term “Microcap Stock” refers to shares (1) traded over the counter or (2) that are listed on Nasdaq and NYSE American that have a market capitalization of between $50 million to $300 million and are trading at or below $5. For purposes of this policy, the term Microcap Stock will include the shares of U.S. public companies which have a market capitalization at or below $50 million, which are sometimes referred to as nanocap stocks or trade on a market generally associated with Microcap Stocks.

To avoid situations where minor, short-term fluctuations in a stock price cause repeated reclassification, any stock classified as U.S. Microcap will remain in that classification until both its market capitalization and share price  exceed $500 million and $5, respectively, for a 30 consecutive calendar day period.

As Microcap Stocks are often low-priced, they are commonly referred to as penny stocks. IBKR may make exceptions, including for stocks traded at low prices that recently had a greater market cap. In addition, IBKR will not consider ADRs on non-US companies to be Micro-Cap stocks.


Where do Microcap Stocks trade?
Microcap Stocks typically trade in the OTC market, rather than on a national securities exchange. They are often electronically quoted by market makers on OTC systems such as the OTC Bulletin Board (OTCBB) and the markets administered by the OTC Markets Group (e.g., OTCQX, OTCQB & Pink). Also included in this category are stocks which may not be publicly quoted and which are designated as Caveat Emptor, Other OTC or Grey Market.
In addition, U.S. regulators also consider stocks listed on Nasdaq or NYSE American trading at or below $5 with a market capitalization at or less than $300 million to be Microcap Stocks.

What happens if IBKR receives a transfer from an Eligible Client where one or more of the positions transferred is a Microcap Stock?
If IBKR receives a transfer containing a block of a Microcap stock, IBKR reserves the right to restrict the sale of any Microcap position(s) included in the transfer unless the Eligible Client provides appropriate documentation establishing that the shares were either purchased on the open market (i.e., on a public exchange through another broker) or were registered with the SEC pursuant to an S-1 or similar registration statement.

Eligible Clients can prove that shares were purchased on the open market by providing a brokerage statement or trade confirm from a reputable broker reflecting the purchase of the shares on a public exchange. Eligible Clients can establish that the shares are registered by providing the SEC (Edgar system) File number under which their shares were registered by the company (and any documents necessary to confirm the shares are the ones listed in the registration statement).

NOTE: All customers are free to transfer out any shares we have restricted at any time.
 

What restrictions will IBKR apply to Prime accounts?
Clients whose activities include Prime services are considered Eligible Clients solely for the purposes of those trades which IBKR has agreed to accept from its executing brokers. However, while Prime accounts may clear U.S. Microcap Stocks at IBKR, those shares will be restricted until such time IBKR confirms that the shares are eligible for re-sale under the procedures discussed above.  To remove the restriction for shares purchased on the open market, please provide an official Account Statement or Trade Confirmation from the executing broker or have the executing broker provide a signed letter, on company letterhead, showing the IBKR account name and number, stating that the shares were purchased in the open market, along with the details of the executions (date, time, quantity, symbol, price, and exchange).  Or if the shares were acquired through an offering the letter must provide documents or links to the relevant registration statement and state that the shares were part of it.

To summarize: Sell Long trades will be accepted if the long position is no longer restricted.  Sell Short trades will be accepted.  Buy Long trades will be accepted and the position will be restricted until Compliance is provided with sufficient information to remove the restriction.  Buy Cover trades and intraday round trip trades will not be accepted.

 

What happens if a stock you purchase gets reclassified as Grey Market or Caveat Emptor?
If you purchase a stock in your IBKR account that at a later date becomes classified as a Caveat Emptor or Grey Market stock, you will be allowed to maintain, close or transfer the position but will not be able to increase your position.

 

Where can I find a list of stocks that IBKR has designated as U.S. Microcaps?

A list of stocks designated as U.S. Microcaps by IBKR is available via the following link: www.ibkr.com/download/us_microcaps.csv

Note that this list is updated daily.

Where can I find additional information on Microcap Stocks?
Additional information on Microcap Stocks, including risks associated with such stocks may be found on the SEC website: https://www.sec.gov/reportspubs/investor-publications/investorpubsmicrocapstockhtm.html
-----------------------------------------------------------
1This includes transfers by any method (e.g., ACATS, DWAC, FOP), conversion of Canadian listings to their U.S. equivalent via “Southbound” transfer, transfers to cover existing short positions, IB Prime customers executing with other brokers and clearing to IBKR, etc.

 

IEX Discretionary Peg Order

Background: 

IEX offers a Discretionary Peg™ (D-Peg™) order type which is a non-displayed order that is priced at either the National Best Bid (NBB for buys) or National Best Offer (NBO for sells). D-Peg™ orders passively rest on the book while seeking to access liquidity at a more aggressive price up to Midpoint of the NBBO, except when IEX determines that the quote is transitioning to less aggressive price

D-Peg™ combines elements of Midpoint Peg, Primary Peg, and traditional discretionary order types.
 
Information about slow and predictable changes in the NBBO are detected in IEX's Crumbling Quote Indicator and provides D-Peg™ orders with an instruction to stop seeking access to liquidity at a more aggressive price until the quote returns to a stable state.

 

How to Place a D-Peg Order

Please note, the IEX D-Peg order type is only available via the TWS version 961 and above. Instructions for entering this order type are outlined below:

Step 1

Enter a symbol and choose a directed quote, selecting IEX as the destination. Right click on the data line and select Trade followed by Order Ticket to open the Order Ticket window.

 

Step 2

Select the REL order type from the Order Type drop down menu.

 

Step 3

Click on the Miscellaneous tab (Misc.) and at the bottom there will be a checkbox for "Discretionary up to limit". Check this box. The price that you set in the Limit Price field will be used at the discretionary price on the order.

 

 

Step 4 

Hit Preview to view the Order Preview window.

 

 

For additional information concerning this order type, please review the following exchange website link: https://www.iextrading.com/trading/dpeg/

 

 

Syndicate content